IDEAYA Biosciences Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, IDEAYA Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $51.92. The average 1-year stock price forecast is 62.45% higher than the current stock price, while the lowest is $31 (-3.00%) and the highest is $65 (+103.38%).

Price Target: $51.92 (+62.45%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$31	$51.92	$51	$65
Change	-3.00%	+62.45%	+59.57%	+103.38%

Analyst Ratings

The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	13	11	11	11	10	12
Buy	3	3	3	3	3	3
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	18	16	15	15	14	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $50 → $44	Buy	Maintains	$50 → $44	+37.67%	Oct 29, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $48	Buy	Maintains	$48	+50.19%	Oct 28, 2026
Michael Yee UBS	UBS	Buy Maintains $50	Buy	Maintains	$50	+56.45%	Oct 27, 2026
Anupam Rama J.P. Morgan	J.P. Morgan	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Oct 27, 2026
Laura Prendergast Stifel Nicolaus	Stifel Nicolaus	Buy Maintains $48	Buy	Maintains	$48	+50.19%	Oct 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

41.01M

from 218.71M

-81.25%

from 218.71M

Revenue Next Year

118.30M

from 41.01M

188.45%

from 41.01M

EPS This Year

-4.59

from -1.28

EPS Next Year

-4.11

from -4.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	27.94M	50.93M	23.39M	7.00M	218.71M	41.01M
Revenue Growth	43.01%	82.28%	-54.09%	-70.07%	3,024.43%	-81.25%
Operating Income	-50.27M	-62.50M	-134.43M	-326.98M	-159.31M	-470.26M
Net Income	-49.76M	-58.66M	-112.96M	-274.48M	-113.70M	-434.14M
EPS	-	-	-	-	-1.28	-4.59
Free Cash Flow	-	-	-	-	-73.47M	-377.80M
No. Analysts	-	-	-	-	-	16

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	85.5M
Avg	41.0M
Low	15.4M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-60.9%
Avg	-81.2%
Low	-93.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-4.02
Avg	-4.59
Low	-5.20

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-